Navigation Links
CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
Date:6/16/2009

ages over current agents for depression and are expected to have a good safety profile. The company's CNS pipeline also includes CXB909, a small molecule, orally active agent for the prevention and treatment of neuropathies and neurodegenerative disorders; a series of novel compounds for anxiety and depression; and a series of selective cannabinoid compounds that have recently completed successful preclinical proof-of-concept studies for the treatment of pain, glaucoma and spasticity. More information about CeNeRx BioPharma can be found at www.cenerx.com.

    Contact:
    GendeLLindheim BioCom Partners
    Barbara Lindheim
    212 918 4650


'/>"/>
SOURCE CeNeRx BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
2. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
3. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
4. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
7. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
8. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
9. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
10. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
11. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced that the Company ... from its partner Asahi Kasei Pharma Corporation (Asahi ... successful submission of a regulatory application to the ... XIAFLEX ® (collagenase clostridium histolyticum) for the ...
(Date:7/30/2014)...  There is still time to share your ... Annual Institute for Supply Management ® – ... Management is open for submissions.  The annual competition ... of supply management by recognizing supply management organizations ... practices.  Entries are due August 22, 2014. ...
(Date:7/30/2014)... CryoLife, Inc. (NYSE: CRY), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2014 of $0.03 per share of common stock ... will be paid on September 19, 2014 to all ... The ex-dividend date for the quarterly dividend is September ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3
... II data show RAD001 significantly increased efficacy of, letrozole tablets in women with newly diagnosed hormone-positive ... cancer, ... ... breast cancer by ...
... Presented at ASCO Annual Meeting -, ... 1 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced safety and efficacy results,from a ... picoplatin and,liposomal doxorubicin in patients with advanced ...
Cached Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5
(Date:7/31/2014)... Rockville, MD (PRWEB) July 31, 2014 ... in San Francisco, announced that they will upgrade all ... including MoSo, MyClub, and MoSo Pay. Motionsoft is a ... cloud-based solutions that automate member management and payments services ... cloud-based member relationship management suite, which FITNESS SF bundled ...
(Date:7/31/2014)... July 31, 2014 Web Programming Services, ... 9001:2008 certified internet marketing firm, has recently launched a ... make this service affordable for everyone, the company has ... service. , Web Programming Services has tailored the ... of brochure designing and likely expectations of the clients ...
(Date:7/31/2014)... News) -- Recovery time after surgery may be reduced ... according to a new study. The study,s Irish ... inflammatory response, reducing the amount of time surgical patients, ... particularly true among people who tend to have healing ... widely prescribed medications in the world. While they are ...
(Date:7/31/2014)... July 31, 2014 Ethane Web ... has introduced a new service named ‘Java Development’. ... Web Technologies has designed the service after doing ... and Java Development service being provided by other ... a confidence to promise outstanding Java Development service. ...
(Date:7/31/2014)... the unusual property of destroying itself after a few hours ... is no stable protein. The protein, called PAI-1, affects many ... get a blood clot, it is due to the fact ... and therefore PAI-1 is extremely important for the human ... blood clot or other blood diseases in which coagulation plays ...
Breaking Medicine News(10 mins):Health News:FITNESS SF Upgrades Motionsoft Software to Include Entire Product Lineup: MoSo + MoSo Pay + MyClub 2Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Cholesterol Drugs May Speed Healing After Surgery 2Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Breakthrough in understanding of important blood protein 2Health News:Breakthrough in understanding of important blood protein 3
... March 3 Shopko has some groundbreaking,news for Council Bluffs. ... as well as a fifth store to the suburban Omaha ... This month, Shopko will open the first new store ... a departure from the look and layout of,current Shopko stores. ...
... Frances Barras of Nederland,Texas, along with her husband ... manufacturers because she has developed mesothelioma from,washing and ... They are represented by Dallas-based Baron & Budd, ... a refinery worker at the,Beaumont DuPont facility between ...
... attack patients have a higher risk for sudden death in ... by researchers from Washington University School of Medicine in St. ... , "There,s a two- to four-fold increase in a person,s ... happen to be depressed," says Robert. M. Carney, Ph.D., lead ...
... Park Dental, a Twin Cities area,group dental practice ... Dental,community for 40-years, announced today that it has ... practice from its Boston, Massachusetts-based,administrative services provider, American ... result of the settlement of a lawsuit in ...
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today that ... Officer and Chairman of,the Board of Directors later this year ... said, "After 15 years at the helm of the company ... right for me to retire from this marvelous,company. Over the ...
... --- Testosterone appears to protect people against eating disorders, ... just social influences -- are linked to anorexia and ... University. , An ongoing, six-year study of 538 sets ... in the womb with male twins have lower risk ...
Cached Medicine News:Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husband's Work Clothes 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 3Health News:Park Dental Announces Separation From Its Administrative Service Provider 2Health News:Park Dental Announces Separation From Its Administrative Service Provider 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3Health News:MSU research indicates testosterone could guard against eating disorders 2
... Shaker provides the exact agitation needed ... very slow to fast speed and ... a gentle wave motion that lifts ... membranes to achieve faster, more uniform ...
Conversion Kits For Modular Incubator Chamber...
Conversion Kits For Modular Incubator Chamber...
Inquire...
Medicine Products: